Objective regressions in non-small cell lung cancer patients treated in Phase I trials of oral ZD1839 (IressaTM), a selective tyrosine kinase inhibitor that blocks the epidermal growth factor receptor (EGFR)

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Phase I Trials ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

125P Association of tumour CD4 positive lymphocytes with prognosis in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor

Annals of Oncology ◽

10.1016/j.annonc.2020.08.246 ◽

2020 ◽

Vol 31 ◽

pp. S290

Author(s):

Y-J. Zhu ◽

H-B. Zhang ◽

X-S. Chang ◽

Z-Z. Xiao ◽

L-R. Liu ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Abstract 3588: Personalized medicine for non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib

10.1158/1538-7445.am10-3588 ◽

2010 ◽

Cited By ~ 1

Author(s):

Akinobu Hamada ◽

Ji-ichiro Sasaki ◽

Sho Saeki ◽

Norihiro Iwamoto ◽

Megumi Inaba ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Efficacy of pemetrexed-based regimens in advanced non–small cell lung cancer patients with activating epidermal growth factor receptor mutations after tyrosine kinase inhibitor failure: a systematic review

OncoTargets and Therapy ◽

10.2147/ott.s157370 ◽

2018 ◽

Vol Volume 11 ◽

pp. 2121-2129 ◽

Cited By ~ 3

Author(s):

Han Bao Hui ◽

Lu Lu Yang ◽

Xin Wang ◽

Luan Di Yao

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Phosphorylation, But Not Overexpression, of Epidermal Growth Factor Receptor Is Associated With Poor Prognosis of Non-Small Cell Lung Cancer Patients

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ◽

10.3727/096504003108748348 ◽

2003 ◽

Vol 13 (5) ◽

pp. 289-298 ◽

Cited By ~ 52

Author(s):

Takanori Kanematsu ◽

Seiji Yano ◽

Hisanori Uehara ◽

Yoshimi Bando ◽

Saburo Sone

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Poor Prognosis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth Factor Receptor exon 20 insertion variants in Non-Small Cell Lung Cancer patients

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2021.103536 ◽

2021 ◽

pp. 103536

Author(s):

Umberto Malapelle ◽

Sara Pilotto ◽

Maria Lucia Reale ◽

Francesco Passiglia ◽

Pasquale Pisapia ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Exon 20

Afatinib treatment in a large real‐world cohort of non‐small cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation

International Journal of Cancer ◽

10.1002/ijc.33821 ◽

2021 ◽

Author(s):

Chi‐Hsien Huang ◽

Jia‐Shiuan Ju ◽

Tzu‐Hsuan Chiu ◽

Allen Chung‐Cheng Huang ◽

Pi‐Hung Tung ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Patients ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Icotinib improves progression free survival in epidermal growth factor receptor positive non-small cell lung cancer patients

Translational Cancer Research ◽

10.21037/tcr.2018.01.15 ◽

2018 ◽

Vol 7 (S1) ◽

pp. S26-S30

Author(s):

Pranav Gupta ◽

Anna Maria Barbuti ◽

De-Shen Wang ◽

Qingbin Cui ◽

Zhe-Sheng Chen

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Growth Factor Receptor ◽

Progression Free Survival ◽

Small Cell ◽

Small Cell Lung ◽

Free Survival ◽

Lung Cancer Patients ◽

Epidermal Growth Factor Receptor Mutations in Resectable Non-Small Cell Lung Cancer Patients and their Potential Role in the Immune Landscape

Medical Science Monitor ◽

10.12659/msm.920042 ◽

2019 ◽

Vol 25 ◽

pp. 8764-8776

Author(s):

Wei Xia ◽

Wenjun Mao ◽

Ruo Chen ◽

Rongguo Lu ◽

Feng Liu ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Potential Role ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients

European Journal of Cancer ◽

10.1016/j.ejca.2019.05.032 ◽

2019 ◽

Vol 117 ◽

pp. 107-115 ◽

Cited By ~ 7

Author(s):

Zong-Han Yao ◽

Wei-Yu Liao ◽

Chao-Chi Ho ◽

Kuan-Yu Chen ◽

Jin-Yuan Shih ◽

...

Keyword(s):

Lung Cancer ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Inhibitor Treatment

Targeting Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer by Inducing Epidermal Growth Factor Receptor DegradationviaMethionine 790 Oxidation

Antioxidants and Redox Signaling ◽

10.1089/ars.2015.6420 ◽

2016 ◽

Vol 24 (5) ◽

pp. 263-279 ◽

Cited By ~ 39

Author(s):

Elaine Lai-Han Leung ◽

Xing-Xing Fan ◽

Maria Pik Wong ◽

Zhi-Hong Jiang ◽

Zhong-Qiu Liu ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽